Advertisement
Case Report| Volume 19, ISSUE 4, 104563, April 2023

Congenital Cytomegalovirus Infection

Published:February 21, 2023DOI:https://doi.org/10.1016/j.nurpra.2023.104563

      Highlights

      • Congenital cytomegalovirus (CMV) is the most common congenital infection and the leading cause of nongenetic sensorineural hearing loss in children.
      • Congenital CMV is associated with cognitive deficits, developmental delays, and sensorineural hearing loss, but recognition is often delayed by parents and providers.
      • A case of congenital CMV infection resulting in neurodevelopmental delays and sensorineural hearing loss is presented.

      Abstract

      Congenital cytomegalovirus (CMV) infection is the most common intrauterine infection and is the leading nongenetic cause of sensorineural hearing loss and neurodevelopmental delays in the pediatric population. Despite its high prevalence and significant sequelae, congenital CMV in the pregnant woman and neonate often goes undiagnosed. We present the case of a 23-month-old child presenting with developmental delays and bilateral sensorineural hearing loss as a result of CMV and describe with this case report the clinical features, diagnosis, testing, management, and prognosis of congenital CMV.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Krstanović F.
        • Britt W.J.
        • Jonjić S.
        • Brizić I.
        Cytomegalovirus infection and inflammation in developing brain.
        Viruses. 2021; 13: 1078https://doi.org/10.3390/v13061078
        • Pesch M.H.
        • Kuboushek K.
        • McKee M.M.
        • Thorne M.C.
        • Weinberg J.B.
        Congenital cytomegalovirus infection.
        BMJ. 2021; 373: n1212https://doi.org/10.1136/bmj.n1212
        • Andronaco D.W.
        Congenital cytomegalovirus and hearing loss.
        J Obstet Gynecol Neonatal Nurs. 2020; 49: 293-304https://doi.org/10.1016/j.jogn.2020.02.005
        • National CMV Foundation
        Healthcare Provider Information and Resources.
        • Fulkerson H.J.
        • Nogalski M.T.
        • Collins-McMillen D.
        • Yurochko A.D.
        Overview of human cytomegalovirus pathogenesis.
        Methods Mol Biol. 2021; 2244: 1-18https://doi.org/10.1007/978-1-0716-1111-1_1
        • Centers for Disease Control and Prevention
        Cytomegalovirus (CMV) and Congenital CMV Infection.
        • Goderis J.
        • De Leenheer E.
        • Smets K.
        • Van Hoecke H.
        • Keymeulen A.
        • Dhooge I.
        Hearing loss and congenital CMV infection: a systematic review.
        Pediatrics. 2014; 134: 972-982
        • Lanzieri T.M.
        • Leung J.
        • Caviness A.C.
        • et al.
        Long-term outcomes of children with symptomatic congenital cytomegalovirus disease.
        J Perinatol. 2017; 37: 875-880https://doi.org/10.1038/jp.2017.41
        • Gantt S.
        • Bitnun A.
        • Renaud C.
        • Kakkar F.
        • Vaudry W.
        Diagnosis and management of infants with congenital cytomegalovirus infection.
        Paediatr Child Health. 2017; 22: 72-74https://doi.org/10.1093/pch/pxx002
        • Health Resources & Services Administration
        Advisory Committee on Heritable Disorders in Newborns and Children. Recommended Uniform Screening Panel. As of August 2022.
        • National CMV Foundation
        National CMV Foundation Nominates Congenital CMV for RUSP Newborn Screening. April 2019.
        • Kimberlin D.W.
        • Jester P.M.
        • Sánchez P.J.
        • et al.
        National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease.
        N Engl J Med. 2015; 372: 933-943https://doi.org/10.1056/NEJMoa1404599
        • Rawlinson W.D.
        • Boppana S.B.
        • Fowler K.B.
        • et al.
        Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.
        Lancet Infect Dis. 2017; 17: e177-e188https://doi.org/10.1016/S1473-3099(17)30143-3
        • Pasternak Y.
        • Ziv L.
        • Attias J.
        • Amir J.
        • Bilavsky E.
        Valganciclovir is beneficial in children with congenital cytomegalovirus and isolated hearing loss.
        J Pediatr. 2018; 199: 166-170https://doi.org/10.1016/j.jpeds.2018.02.028
        • Moderna
        A Clinical Trial of a Cytomegalovirus (CMV) Infection in Healthy Women 16 to 40 Years of Age. Moderna Clinical Trials. 2020.

      Biography

      Michelle P. Zappas, DNP, FNP-BC is a clinical associate professor in the Department of Nursing at the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles, and can be contacted at [email protected]

      Biography

      Sharon P. O'Neill, DNP, JD, FNP-BC, PMHNP-BC, is a clinical associate professor at the New York University Rory Meyers College of Nursing, New York.

      Biography

      Courtney Rotz, MSN, FNP-BC, is an adjunct professor in the Department of Nursing at the Suzanne Dworak-Peck School of Social Work, University of Southern California, Los Angeles.